Human cytomegalovirus virion-associated mRNA as a marker of
productive infection in immunocompromised patients.
Federica Giardina1, Stefania
Paolucci2,*, Dalila Mele2, Omar
Mura2, Marina Ramus2, José Camilla
Sammartino1, Piera d’Angelo2,
Antonino Maria Guglielmo Pitrolo2, Giulia
Campanini2, Eleonora Francesca
Pattonieri3, Teresa Rampino3,4,
Marilena Gregorini3,4, Francesca
Compagno5, Domenica Federica
Briganti6, Elena Seminari7, Nicola
Polverelli8, Irene Cassaniti1,2,
Daniele Lilleri1, Fausto
Baldanti1,2.
1Department of Clinical Surgical Diagnostic and
Pediatric Sciences, Università degli Studi di Pavia, Italy
2Microbiology and Virology, Fondazione IRCCS
Policlinico San Matteo, Pavia, Italy
3Nephrology, Dialysis and Transplantation, Fondazione
IRCCS Policlinico San Matteo, Pavia, Italy
4Department of Internal Medicine and Therapeutics,
University of Pavia, Pavia, Italy
5Pediatric Oncohematology, Fondazione IRCCS
Policlinico San Matteo, Pavia, Italy
6Transplant Center, Fondazione IRCCS Policlinico San
Matteo, Pavia, Italy
7Infectious Diseases I, Fondazione IRCCS Policlinico
San Matteo, Pavia, Italy
8Hematology, Fondazione IRCCS Policlinico San Matteo,
Pavia, Italy
*Corresponding author:
Stefania Paolucci; email:
s.paolucci@smatteo.pv.it
Running head: Virion-associated CMV mRNA in plasma